General
Preferred name
UPF-648
Synonyms
UPF-648 (sodium salt) ()
UPF 648 ()
UPF-648 sodium salt ()
P&D ID
PD016428
CAS
213400-34-1
1465017-87-1
Tags
available
drug candidate
Drug indication
Neurodegenerative disorder
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Potent ROCK inhibitor; orally bioavailable
(Tocris Bioactive Compound Library)
DESCRIPTION
Potent and selective inhibitor of kynurenine-3-monooxygenase (KMO, or kynurenine hydroxylase) activity (IC50: 20 nM); Active (+)-(1S,2S)-enantiomer; Useful tool for research on cognitive enhancement and neuroprotection in the brain.
(BOC Sciences Bioactive Compounds)
DESCRIPTION
UPF-648 sodium salt is a potent kynurenine 3-monooxygenase (KMO) inhibitor; exhibits highly active at 1 uM (81 ± 10% KMO inhibition); ineffective at blocking KAT activity.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
7
Axon Medchem Screening Library
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
DrugMAP
MedChem Express Bioactive Compound Library
Other bioactive compounds
Tocris Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
19
Molecular Weight
257.99
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
1
Rotatable Bonds
3
Ring Count
2
Aromatic Ring Count
1
cLogP
2.9
TPSA
54.37
Fraction CSP3
0.27
Chiral centers
2.0
Largest ring
6.0
QED
0.85
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Primary Target
Kynurenine 3-monooxygenase
MOA
Inhibitor
Target
Reactive Oxygen Species
KMO inhibitor
Aryl hydrocarbon receptor
Pathway
Metabolic Enzyme/Protease
NF-¦ÊB
Immunology/Inflammation
Source data

